Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

AXL is a Putative Tumor Suppressor and Dormancy Regulator in Prostate Cancer.

Axelrod HD, Valkenburg KC, Amend SR, Hicks JL, Parsana P, Torga G, De Marzo AM, Pienta KJ.

Mol Cancer Res. 2018 Oct 5. pii: molcanres.0718.2018. doi: 10.1158/1541-7786.MCR-18-0718. [Epub ahead of print]

PMID:
30291220
2.

Optimization of Immunofluorescent Detection of Bone Marrow Disseminated Tumor Cells.

Axelrod HD, Pienta KJ, Valkenburg KC.

Biol Proced Online. 2018 Jul 1;20:13. doi: 10.1186/s12575-018-0078-5. eCollection 2018.

3.

Ten unanswered questions in cancer: "If this is true, what does it imply"?

Amend SR, de Groot AE, Torga G, Axelrod HD, Reyes DK, Valkenburg KC, Glavaris SA, Pienta KJ.

Am J Clin Exp Urol. 2018 Apr 1;6(2):26-31. eCollection 2018. No abstract available.

4.

Targeting the tumour stroma to improve cancer therapy.

Valkenburg KC, de Groot AE, Pienta KJ.

Nat Rev Clin Oncol. 2018 Jun;15(6):366-381. doi: 10.1038/s41571-018-0007-1. Review.

PMID:
29651130
5.

Deletion of tumor suppressors adenomatous polyposis coli and Smad4 in murine luminal epithelial cells causes invasive prostate cancer and loss of androgen receptor expression.

Valkenburg KC, De Marzo AM, Williams BO.

Oncotarget. 2017 May 17;8(46):80265-80277. doi: 10.18632/oncotarget.17919. eCollection 2017 Oct 6.

6.

A simple selection-free method for detecting disseminated tumor cells (DTCs) in murine bone marrow.

Valkenburg KC, Amend SR, Verdone JE, van der Toom EE, Hernandez JR, Gorin MA, Pienta KJ.

Oncotarget. 2016 Oct 25;7(43):69794-69803. doi: 10.18632/oncotarget.12000.

7.

Murine Prostate Micro-dissection and Surgical Castration.

Valkenburg KC, Amend SR, Pienta KJ.

J Vis Exp. 2016 May 11;(111). doi: 10.3791/53984.

8.

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation.

Amend SR, Valkenburg KC, Pienta KJ.

J Vis Exp. 2016 Apr 14;(110). doi: 10.3791/53936.

9.

Concurrent Hepsin overexpression and adenomatous polyposis coli deletion causes invasive prostate carcinoma in mice.

Valkenburg KC, Hostetter G, Williams BO.

Prostate. 2015 Oct;75(14):1579-85. doi: 10.1002/pros.23032. Epub 2015 Jul 2.

PMID:
26139199
10.

Drug discovery in prostate cancer mouse models.

Valkenburg KC, Pienta KJ.

Expert Opin Drug Discov. 2015;10(9):1011-24. doi: 10.1517/17460441.2015.1052790. Epub 2015 Jun 1. Review.

11.

Activation of Wnt/β-catenin signaling in a subpopulation of murine prostate luminal epithelial cells induces high grade prostate intraepithelial neoplasia.

Valkenburg KC, Yu X, De Marzo AM, Spiering TJ, Matusik RJ, Williams BO.

Prostate. 2014 Nov;74(15):1506-20. doi: 10.1002/pros.22868. Epub 2014 Aug 29.

12.

Skeletal metastasis: treatments, mouse models, and the Wnt signaling.

Valkenburg KC, Steensma MR, Williams BO, Zhong Z.

Chin J Cancer. 2013 Jul;32(7):380-96. doi: 10.5732/cjc.012.10218. Epub 2013 Jan 18. Review.

13.

Mouse models of prostate cancer.

Valkenburg KC, Williams BO.

Prostate Cancer. 2011;2011:895238. doi: 10.1155/2011/895238. Epub 2011 Feb 23.

14.

Wnt/β-catenin Signaling in Normal and Cancer Stem Cells.

Valkenburg KC, Graveel CR, Zylstra-Diegel CR, Zhong Z, Williams BO.

Cancers (Basel). 2011 Apr 19;3(2):2050-79. doi: 10.3390/cancers3022050.

Supplemental Content

Loading ...
Support Center